TP53 and liver cancer: Recent studies in liver cancer and sarcoma mouse models suggest that reactivation of p53 in p53-deficient tumors in vivo produces complete tumor regression predominately due to senescence induction (Ventura et al., 2007; Xue et al., 2007).